Join Experts from the CDC and CARB-X to Learn More About the Challenges in Addressing AMR Amid COVID-19 and Beyond
The Partnership to Fight Infectious Disease (PFID) invites you to an important discussion among experts on the existing and growing threats associated with AMR, the connection to COVID-19, and what’s at stake if we don’t take action. This virtual event will highlight both public health prevention efforts and policy changes that can make a difference, especially for the millions of Americans who are most vulnerable to AMR and COVID-19.
Our pipeline of novel antibiotics is dwindling at the same time that antibiotic overuse and misuse is growing, creating a dangerous perfect storm for drug-resistant infections. Meanwhile, COVID-19 has revealed what’s at stake when we’re not prepared for global health emergencies. Antibiotics are critical to modern medicine, but without action to address the rising threats of “super bugs,” AMR could be the next pandemic. As we approach flu season in the midst of the COVID-19 pandemic—combined with the threat of AMR—concerns are high about what all these issues could mean for compounded illnesses, clinical exposure, antibiotic use, and more. Join us to learn more about what’s being done today and how we can do more moving forward.
Please feel free to submit a question using the box below. Questions may also be submitted during the webinar and we will reserve time to try and answer as many as possible.